[1]
N. S. Chandhok and M. W. Saif, “Updates on the Use of Neoadjuvant Therapy in Borderline Resectable Pancreatic Cancer”, JOP. J Pancreas (Online), vol. 15, no. 2, pp. 91–94, Mar. 2014.